By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > CNS stimulants > Daytrana patch
CNS stimulants

Daytrana patch

https://themeditary.com/drug/daytrana-patch-1398.html
Medically Reviewed by Philip Thornton, DipPharm TheMediTary.Com | Reviewed: Jul 13, 2023  Additional Content by TheMediTary.Com

Generic name: methylphenidate (transdermal) [ meth-il-fen-ih-date ]

Drug class: CNS stimulants

Dosage form: patch

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Concerta, Jornay pm, Quillichew er, Quillivant xr, Ritalin

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Daytrana patch?

Daytrana is a skin patch that is applied to the skin on your hip. The patch contains methylphenidate, a central nervous system (brain) stimulant. Methylphenidate affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control.

Daytrana patches are used to treat attention deficit hyperactivity disorder (ADHD) in people 6 to 17 years old.

Daytrana may help you have better attention and less impulsive and hyperactive behavior. Daytrana is used as part of a total treatment program for ADHD that may also include counseling or other treatments.

Warnings

Daytrana may cause new or worsening psychosis (unusual thoughts or behavior), especially if you have a history of depression, mental illness, or bipolar disorder.

You should not use Daytrana if you have glaucoma, tics or Tourette's syndrome, or severe anxiety, tension, or agitation. Do not use methylphenidate if you have taken an MAO inhibitor in the past 14 days, including isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.

Daytrana may be habit-forming. Tell your doctor if you have a history of drug or alcohol addiction. Keep the medication where others cannot get to it. Never share Daytrana patches with another person, especially someone with a history of drug abuse or addiction.

Stimulants have caused stroke, heart attack, and sudden death in people with high blood pressure, heart disease, or a heart defect.

Call your doctor right away if you have: signs of heart problems - chest pain, feeling light-headed or short of breath; or signs of psychosis - paranoia, aggression, new behavior problems, seeing or hearing things that are not real.

How should I take Daytrana patch

Use Daytrana exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.

Daytrana may be habit-forming. Misuse can cause addiction, overdose, or death. Keep the medication in a place where others cannot get to it. Selling or giving away this Daytrana is against the law.

Apply the Daytrana patch to a clean and dry area on your hip. The effects of this medicine may not be noticeable until 2 hours after applying the skin patch.

Wash your hands after applying a skin patch.

Remove the Daytrana patch 9 hours after it was applied. Peel off slowly and fold the patch in half so it sticks together. Flush the folded patch down the toilet or place it into a waste can with a lid.

Apply each new Daytrana patch to the opposite hip. Do not wear more than one patch at a time. Never cut a skin patch.

If a Daytrana patch falls off, replace it with a new one. Do not wear a patch longer than 9 hours per day, even if you apply a new patch to replace one that has fallen off.

If you have loss of appetite or trouble sleeping, ask your doctor if you can remove the skin patch earlier in the day.

Children using this medicine should be warned never to remove the skin patch and place it onto another person. Serious side effects may result.

Over time, Daytrana can cause your skin to lighten around areas where the patches are worn. This effect may be permanent. Tell your doctor if you see new areas of lighter color under or around a skin patch, or if skin lightens on other areas of your body.

Your doctor will need to check your progress on a regular basis. Your heart rate, blood pressure, height and weight may also need to be checked often.

Store at room temperature. Do not refrigerate or freeze. Keep each Daytrana patch in its sealed pouch until you are ready to use it. Throw away unused patches if it has been more than 2 months since you opened the original package.

Keep your medicine in a place where no one can use it improperly.

If you discontinue using Daytrana, fold together and flush any unused patches at that time.

Dosing information

Usual Pediatric Dose for Attention Deficit Disorder:

Apply a Daytrana patch 2 hours before effect is needed and remove 9 hours after application; recommended dose titration schedule:
Week 1: Apply 10 mg patch to hip area once a day; remove 9 hours later
Week 2: Apply 15 mg patch to hip area once a day; remove 9 hours later
Week 3: Apply 20 mg patch to hip area once a day; remove 9 hours later
Week 4: Apply 30 mg patch to hip area once a day; remove 9 hours later
-Individualize final dose and wear time to needs and response of the patient; patients converting from other formulation of methylphenidate should follow the above titration schedule.

Detailed Daytrana dosage information
Daytrana patch Dosage information (more detail)

Before Taking

You should not use Daytrana if you are allergic to methylphenidate (Ritalin, Concerta, Metadate, and others), or if you have:

  • glaucoma;

  • tics (muscle twitches);

  • a personal or family history of Tourette's syndrome;

  • severe anxiety, tension, or agitation; or

  • if you have ever had a skin reaction to a Daytrana skin patch.

Stimulants have caused stroke, heart attack, and sudden death in certain people. Tell your doctor if you have:

  • heart problems or a congenital heart defect;

  • high blood pressure; or

  • a family history of heart disease or sudden death.

Do not use Daytrana if you have taken an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, and tranylcypromine.

Tell your doctor if you also use opioid medicine, herbal products, or medicine for depression, mental illness, Parkinson's disease, migraine headaches, serious infections, or prevention of nausea and vomiting. An interaction with Daytrana could cause a serious condition called serotonin syndrome.

To make sure Daytrana is safe for you, tell your doctor if you have ever had:

  • a skin disorder (such as eczema, psoriasis), skin sensitivity to soaps, lotions, cosmetics, or glues;

  • vitiligo (loss of skin color in patches) in you or a family member;

  • depression, mental illness, bipolar disorder, psychosis, or suicidal thoughts or actions;

  • blood circulation problems in your hands or feet;

  • a seizure;

  • an abnormal brain wave test (EEG); or

  • drug or alcohol addiction.

Becoming dependent on this medicine during pregnancy can cause premature birth or low birth weight. Tell your doctor if you are pregnant or plan to become pregnant. If you are pregnant, your name may be listed on a pregnancy registry to track the effects of>methylphenidate on the baby.

Ask a doctor if it is safe to breastfeed while using Daytrana. If you are breastfeeding, tell your doctor if you notice symptoms in the baby such as agitation, sleep problems, feeding problems, or reduced weight gain.

Daytrana is not approved for use by anyone younger than 6 years old.

Daytrana pregnancy and breastfeeding warnings (more detail)

What happens if I miss a dose?

Apply a patch as soon as you remember, and do not wear it for longer than 9 hours. You may need to shorten the wearing time if you apply a patch later than usual. Do not wear two patches at the same time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. Remove the patch right away and clean the skin area with soap and water. An overdose of methylphenidate can be fatal.

Overdose symptoms may include sweating, redness in your face, vomiting, shaking, confusion, agitation, hallucinations, and irregular heartbeat.

What should I avoid while using Daytrana patch?

Do not expose the Daytrana patch to heat while you are wearing it. This includes heat from a heating pad, hair dryer, electric blanket, or a heated water bed. Heat can cause the skin patch to release too much medicine at one time.

Avoid using any lotions or creams on skin where you will apply a Daytrana patch. Avoid placing a patch on skin that will be rubbed by a waistband or tight clothing.

Avoid driving or hazardous activity until you know how methylphenidate will affect you. Your reactions could be impaired.

Daytrana patch side effects

Get emergency medical help if you have signs of an allergic reaction to Daytrana: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using Daytrana and call your doctor at once if you have:

  • redness, swelling, blistering, or skin color changes where the skin patch was worn (may also spread to other areas);

  • blurred vision;

  • a seizure;

  • signs of heart problems - chest pain, trouble breathing, feeling like you might pass out;

  • signs of psychosis - hallucinations (seeing or hearing things that are not real), new behavior problems, aggression, hostility, paranoia;

  • signs of circulation problems - numbness, pain, cold feeling, unexplained wounds, or skin color changes (pale, red, or blue appearance) in your fingers or toes; or

  • penis erection that is painful or lasts 4 hours or longer.

Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.

Methylphenidate can affect growth in children. Your child's height and weight may need to be checked often. Tell your doctor if your child is not growing at a normal rate.

Common Daytrana side effects may include:

  • dizziness, mood swings;

  • tics;

  • nausea, vomiting, stomach pain, loss of appetite, weight loss;

  • sleep problems (insomnia); or

  • skin redness, bumps, or itching where a patch was worn.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Daytrana patch Side Effects

What other drugs will affect Daytrana patch?

Tell your doctor about all your other medicines, especially:

  • an antidepressant;

  • blood pressure medication;

  • a blood thinner such as warfarin (Coumadin, Jantoven);

  • a cold or allergy medicine that contains a decongestant such as pseudoephedrine or phenylephrine; or

  • seizure medicine.

This list is not complete. Other drugs may interact with methylphenidate, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

More about Daytrana patch (Methylphenidate (transdermal) [ meth-il-fen-ih-date ])

Dosage information
Daytrana patch Side Effects
During pregnancy
Daytrana Prescribing Information
Drug images
Side effects
Drug class: CNS stimulants

Related treatment guides

ADHD
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by